Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Characteristics of Obstructive Sleep Apnea Across the Spectrum of Glucose Tolerance in Obese Adolescents.

Hannon TS, Watson SE, Jalou HE, Chakravorty S, Mather KJ, Arslanian SA.

Front Endocrinol (Lausanne). 2018 Jun 1;9:281. doi: 10.3389/fendo.2018.00281. eCollection 2018.

2.

Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Kelsey MM, Braffett BH, Geffner ME, Levitsky LL, Caprio S, McKay SV, Shah R, Sprague JE, Arslanian SA; TODAY Study Group.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2309-2318. doi: 10.1210/jc.2018-00132.

3.

Response to Letter: "Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline".

Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2123-2124. doi: 10.1210/jc.2017-00561. No abstract available.

4.

Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.

Hannon TS, Kahn SE, Utzschneider KM, Buchanan TA, Nadeau KJ, Zeitler PS, Ehrmann DA, Arslanian SA, Caprio S, Edelstein SL, Savage PJ, Mather KJ; RISE Consortium.

Diabetes Obes Metab. 2018 Jan;20(1):14-24. doi: 10.1111/dom.13005. Epub 2017 Jun 22. Review.

5.

Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):709-757. doi: 10.1210/jc.2016-2573.

6.

Race or vitamin D: A determinant of intima media thickness in obese adolescents?

Bacha F, Arslanian SA.

Pediatr Diabetes. 2017 Nov;18(7):619-621. doi: 10.1111/pedi.12472. Epub 2016 Nov 17.

PMID:
27860112
7.

Maternal excess gestational weight gain and infant waist circumference: a 2-y observational study.

Michaliszyn SF, Sjaarda LA, Scifres C, Simhan H, Arslanian SA.

Pediatr Res. 2017 Jan;81(1-1):63-67. doi: 10.1038/pr.2016.174. Epub 2016 Sep 15.

8.

Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

Hughan KS, Tfayli H, Warren-Ulanch JG, Barinas-Mitchell E, Arslanian SA.

J Pediatr. 2016 Jan;168:104-11.e1. doi: 10.1016/j.jpeds.2015.09.082. Epub 2015 Nov 3.

9.

The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes.

Hannon TS, Arslanian SA.

Ann N Y Acad Sci. 2015 Sep;1353:113-37. doi: 10.1111/nyas.12939. Epub 2015 Oct 8. Review.

10.

Brain volume and white matter in youth with type 2 diabetes compared to obese and normal weight, non-diabetic peers: A pilot study.

Rofey DL, Arslanian SA, El Nokali NE, Verstynen T, Watt JC, Black JJ, Sax R, Krall JS, Proulx C, Dillon M, Erickson KI.

Int J Dev Neurosci. 2015 Nov;46:88-91. doi: 10.1016/j.ijdevneu.2015.07.003. Epub 2015 Jul 31.

PMID:
26287285
11.

Gestational Weight Gain and Offspring Longitudinal Growth in Early Life.

Diesel JC, Eckhardt CL, Day NL, Brooks MM, Arslanian SA, Bodnar LM.

Ann Nutr Metab. 2015;67(1):49-57.

12.

Gestational weight gain and the risk of offspring obesity at 10 and 16 years: a prospective cohort study in low-income women.

Diesel JC, Eckhardt CL, Day NL, Brooks MM, Arslanian SA, Bodnar LM.

BJOG. 2015 Sep;122(10):1395-402. doi: 10.1111/1471-0528.13448. Epub 2015 May 29.

13.

Is gestational weight gain associated with offspring obesity at 36 months?

Diesel JC, Eckhardt CL, Day NL, Brooks MM, Arslanian SA, Bodnar LM.

Pediatr Obes. 2015 Aug;10(4):305-10. doi: 10.1111/ijpo.262. Epub 2014 Sep 30.

14.

Pre-diabetes in overweight youth and early atherogenic risk.

Burns SF, Lee S, Bacha F, Tfayli H, Hannon TS, Arslanian SA.

Metabolism. 2014 Dec;63(12):1528-35. doi: 10.1016/j.metabol.2014.08.008. Epub 2014 Aug 27.

15.

Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants?

Bacha F, Edmundowicz D, Sutton-Tyrell K, Lee S, Tfayli H, Arslanian SA.

Diabetes Care. 2014 Sep;37(9):2632-9. doi: 10.2337/dc14-0193.

16.

Morning blood pressure is associated with sleep quality in obese adolescents.

Hannon TS, Tu W, Watson SE, Jalou H, Chakravorty S, Arslanian SA.

J Pediatr. 2014 Feb;164(2):313-7. doi: 10.1016/j.jpeds.2013.10.011. Epub 2013 Nov 16.

17.

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; Endocrine Society.

J Clin Endocrinol Metab. 2013 Dec;98(12):4565-92. doi: 10.1210/jc.2013-2350. Epub 2013 Oct 22.

18.

β-Cell lipotoxicity in response to free fatty acid elevation in prepubertal youth: African American versus Caucasian contrast.

Michaliszyn SF, Bonadonna RC, Sjaarda LA, Lee S, Farchoukh L, Arslanian SA.

Diabetes. 2013 Aug;62(8):2917-22. doi: 10.2337/db12-1664. Epub 2013 Apr 4.

19.

Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents.

Hannon TS, Rofey DL, Lee S, Arslanian SA.

Pediatr Diabetes. 2013 Nov;14(7):497-503. doi: 10.1111/pedi.12035. Epub 2013 Mar 31.

20.

β-Cell lipotoxicity after an overnight intravenous lipid challenge and free fatty acid elevation in African American versus American white overweight/obese adolescents.

Hughan KS, Bonadonna RC, Lee S, Michaliszyn SF, Arslanian SA.

J Clin Endocrinol Metab. 2013 May;98(5):2062-9. doi: 10.1210/jc.2012-3492. Epub 2013 Mar 22.

21.

25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes.

de las Heras J, Rajakumar K, Lee S, Bacha F, Holick MF, Arslanian SA.

Diabetes Care. 2013 Jul;36(7):2048-53. doi: 10.2337/dc12-1288. Epub 2013 Jan 22.

22.

Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth.

Michaliszyn SF, Sjaarda LA, Mihalik SJ, Lee S, Bacha F, Chace DH, De Jesus VR, Vockley J, Arslanian SA.

J Clin Endocrinol Metab. 2012 Nov;97(11):E2119-24. doi: 10.1210/jc.2012-2170. Epub 2012 Sep 13.

23.

Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome.

Jakubowski KP, Black JJ, El Nokali NE, Belendiuk KA, Hannon TS, Arslanian SA, Rofey DL.

J Obes. 2012;2012:298067. doi: 10.1155/2012/298067. Epub 2012 Aug 26.

24.

Progressive deterioration of β-cell function in obese youth with type 2 diabetes.

Bacha F, Gungor N, Lee S, Arslanian SA.

Pediatr Diabetes. 2013 Mar;14(2):106-11. doi: 10.1111/j.1399-5448.2012.00915.x. Epub 2012 Aug 23.

25.

HbA(1c) diagnostic categories and β-cell function relative to insulin sensitivity in overweight/obese adolescents.

Sjaarda LA, Michaliszyn SF, Lee S, Tfayli H, Bacha F, Farchoukh L, Arslanian SA.

Diabetes Care. 2012 Dec;35(12):2559-63. doi: 10.2337/dc12-0747. Epub 2012 Aug 21.

26.

Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth.

Burns SF, Lee SJ, Arslanian SA.

J Pediatr. 2012 Dec;161(6):991-6. doi: 10.1016/j.jpeds.2012.06.013. Epub 2012 Jul 17.

27.

Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation.

Mihalik SJ, Michaliszyn SF, de las Heras J, Bacha F, Lee S, Chace DH, DeJesus VR, Vockley J, Arslanian SA.

Diabetes Care. 2012 Mar;35(3):605-11. doi: 10.2337/DC11-1577. Epub 2012 Jan 20.

28.

Obesity is not linked to increased whole-body mast cell burden in children.

Ward BR, Arslanian SA, Andreatta E, Schwartz LB.

J Allergy Clin Immunol. 2012 Apr;129(4):1164-6. doi: 10.1016/j.jaci.2011.11.050. Epub 2012 Jan 12. No abstract available.

29.

25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in black and white youth.

Rajakumar K, de las Heras J, Lee S, Holick MF, Arslanian SA.

Diabetes Care. 2012 Mar;35(3):627-33. doi: 10.2337/dc11-1825. Epub 2012 Jan 11. Erratum in: Diabetes Care. 2012 Oct;35(10):2108.

30.

Relationships among obstructive sleep apnea, anthropometric measures, and neurocognitive functioning in adolescents with severe obesity.

Hannon TS, Rofey DL, Ryan CM, Clapper DA, Chakravorty S, Arslanian SA.

J Pediatr. 2012 May;160(5):732-5. doi: 10.1016/j.jpeds.2011.10.029. Epub 2011 Dec 3.

31.

Differences in stimulated androgen levels in black and white obese adolescent females.

Hannon TS, Arslanian SA.

J Pediatr Adolesc Gynecol. 2012 Feb;25(1):82-5. doi: 10.1016/j.jpag.2011.09.007. Epub 2011 Nov 16.

32.

Type 2 diabetes in youth: are there racial differences in β-cell responsiveness relative to insulin sensitivity?

Bacha F, Gungor N, Lee S, Arslanian SA.

Pediatr Diabetes. 2012 May;13(3):259-65. doi: 10.1111/j.1399-5448.2011.00820.x. Epub 2011 Sep 20.

33.

Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth.

Burns SF, Bacha F, Lee SJ, Tfayli H, Gungor N, Arslanian SA.

Diabetes Care. 2011 Sep;34(9):2033-40. doi: 10.2337/dc11-0423. Epub 2011 Jul 12.

34.

Vitamin D status, adiposity, and lipids in black American and Caucasian children.

Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA.

J Clin Endocrinol Metab. 2011 May;96(5):1560-7. doi: 10.1210/jc.2010-2388. Epub 2011 Mar 2.

35.

Measurement site of visceral adipose tissue and prediction of metabolic syndrome in youth.

Lee S, Kuk JL, Kim Y, Arslanian SA.

Pediatr Diabetes. 2011 May;12(3 Pt 2):250-7. doi: 10.1111/j.1399-5448.2010.00705.x. Epub 2010 Dec 5.

36.

From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation.

Bacha F, Lee S, Gungor N, Arslanian SA.

Diabetes Care. 2010 Oct;33(10):2225-31. doi: 10.2337/dc10-0004. Epub 2010 Jun 30.

37.

Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance.

Hannon TS, Lee S, Chakravorty S, Lin Y, Arslanian SA.

Int J Pediatr Obes. 2011 Apr;6(2):157-60. doi: 10.3109/17477166.2010.482156. Epub 2010 Jun 14.

38.

Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.

Smith RJ, Nathan DM, Arslanian SA, Groop L, Rizza RA, Rotter JI.

J Clin Endocrinol Metab. 2010 Apr;95(4):1566-74. doi: 10.1210/jc.2009-1966. Epub 2010 Mar 1.

39.

Waist circumference, atherogenic lipoproteins, and vascular smooth muscle biomarkers in children.

Burns SF, Arslanian SA.

J Clin Endocrinol Metab. 2009 Dec;94(12):4914-22. doi: 10.1210/jc.2009-1301. Epub 2009 Oct 21.

40.

Family-based treatment of severe pediatric obesity: randomized, controlled trial.

Kalarchian MA, Levine MD, Arslanian SA, Ewing LJ, Houck PR, Cheng Y, Ringham RM, Sheets CA, Marcus MD.

Pediatrics. 2009 Oct;124(4):1060-8. doi: 10.1542/peds.2008-3727. Epub 2009 Sep 28.

41.

In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children.

Burns SF, Lee S, Arslanian SA.

Diabetes Care. 2009 Nov;32(11):2087-93. doi: 10.2337/dc09-0380. Epub 2009 Aug 12.

42.

Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents.

Burns SF, Kelsey SF, Arslanian SA.

Diabetes Care. 2009 Feb;32(2):355-60. doi: 10.2337/dc08-1102. Epub 2008 Nov 18.

43.

In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?

Bacha F, Gungor N, Lee S, Arslanian SA.

Diabetes Care. 2009 Jan;32(1):100-5. doi: 10.2337/dc08-1030. Epub 2008 Oct 3.

44.

Fat oxidation in black and white youth: a metabolic phenotype potentially predisposing black girls to obesity.

Lee S, Arslanian SA.

J Clin Endocrinol Metab. 2008 Nov;93(11):4547-51. doi: 10.1210/jc.2008-1024. Epub 2008 Sep 9.

45.

Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.

Rofey DL, Szigethy EM, Noll RB, Dahl RE, Lobst E, Arslanian SA.

J Pediatr Psychol. 2009 Mar;34(2):156-63. doi: 10.1093/jpepsy/jsn057. Epub 2008 Jun 12.

46.
47.

Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test.

Bacha F, Gungor N, Arslanian SA.

J Pediatr. 2008 May;152(5):618-21. doi: 10.1016/j.jpeds.2007.11.044. Epub 2008 Feb 4.

48.

Race and gender differences in the relationships between anthropometrics and abdominal fat in youth.

Lee S, Kuk JL, Hannon TS, Arslanian SA.

Obesity (Silver Spring). 2008 May;16(5):1066-71. doi: 10.1038/oby.2008.13. Epub 2008 Mar 6.

49.

Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism.

Hannon TS, Danadian K, Suprasongsin C, Arslanian SA.

J Clin Endocrinol Metab. 2007 Aug;92(8):3033-9. Epub 2007 May 22.

PMID:
17519313
50.

Type 2 diabetes in children and adolescents: a review for the primary care provider.

Hannon TS, Gungor N, Arslanian SA.

Pediatr Ann. 2006 Dec;35(12):880-7. Review. No abstract available.

PMID:
17236435

Supplemental Content

Loading ...
Support Center